PACB logo

PACB Pacific Biosciences of California, Inc.

NASDAQ Global Select · Medical - Devices · Healthcare

$1.63
-0.13 (-7.39%)

Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instr…

Market Cap: $508.95Mwww.pacb.com

Price

No data yet.

Social Signal Score

52
5d
—
30d
52
6 mentions
—
60d
52
14 mentions
—
90d
51
20 mentions
—
news: 20

Analyst Ratings

18 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 8Sell 1Strong Sell 0
Avg price target$1.93+18.4%
Low $1.35Median $1.93High $2.5
Current Consensus

Revenue

$40.56M+57.70%
$15.60M$29.85M$44.10M$58.36M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-1.85
$-1.92–$-1.79
4 analysts
FY2026
$-0.44
$-0.45–$-0.42
3 analysts
FY2027
$-0.44
$-0.46–$-0.43
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Mark Van Oene
Sector
Healthcare
Industry
Medical - Devices
Employees
485
Beta
2.20
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-4.97
www.pacb.com